ClassID:

95253

C07D403/14 - page 4 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings

Recent Application in this class:
#901
20230048816
2023-02-16

Pyridazinone compounds and uses thereof

#902
20230047915
2023-02-16

HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

#903
20230047816
2023-02-16

PFKFB3 INHIBITORS AND THEIR USES

#904
20230047296
2023-02-16

Nrf2 REGULATORS

#905
20230046680
2023-02-16

NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES

#906
20230045357
2023-02-09

Biarylmethyl heterocycles

#907
20230044255
2023-02-09

3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same

#908
20230043970
2023-02-09

Certain chemical entities, compositions, and methods

#909
20230043159
2023-02-09

MATRIPTASE 2 INHIBITORS AND USES THEREOF

#910
20230041530
2023-02-09

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#911
20230039997
2023-02-09

1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/CDC42 GTPases

#912
20230039309
2023-02-09

Substituted indole Mcl-1 inhibitors

#913
20230034961
2023-02-02

PROCESS FOR THE PREPARATION OF PIPERIDINE COMPOUNDS

#914
20230032612
2023-02-02

Quaternary indazole glucocorticoid receptor antagonists

#915
20230030720
2023-02-02

CYCLOALKANE-1,3-DIAMINE DERIVATIVE

#916
20230030414
2023-02-02

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

#917
20230030115
2023-02-02

RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF

#918
20230028687
2023-01-26

Quinolin-2-one derivatives

#919
20230027985
2023-01-26

SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS

#920
20230026438
2023-01-26

Protease inhibitors as antivirals

#921
20230025510
2023-01-26

BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES

#922
20230025460
2023-01-26

Light-Emitting Device and Light-Emitting Apparatus

#923
20230025065
2023-01-26

5-HETEROARYL-1H-PYRAZOL-3-AMINE DERIVATIVE

#924
20230023066
2023-01-26

N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#925
20230022524
2023-01-26

HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1

#926
20230022157
2023-01-26

PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS

#927
20230021916
2023-01-26

Modulators of Rho-associated protein kinase

#928
20230020273
2023-01-19

Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha

#929
20230019732
2023-01-19

EGFR INHIBITORS

#930
20230019280
2023-01-19

SUBSTITUTED ISOINDOLONYL 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME

#931
20230019032
2023-01-19

Benzolactam compounds as protein kinase inhibitors

#932
20230015617
2023-01-19

PHTHALAZINONE DERIVATIVES

#933
20230014855
2023-01-19

MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF

#934
20230013823
2023-01-19

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#935
20230012449
2023-01-12

COMPOUNDS FOR THE TREATMENT OF HIV

#936
20230012073
2023-01-12

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

#937
20230010108
2023-01-12

A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP

#938
20230002417
2023-01-05

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#939
20230002362
2023-01-05

BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

#940
20230002359
2023-01-05

PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS

#941
20230002358
2023-01-05

PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME

#942
20230002356
2023-01-05

COMPOUNDS AND USES THEREOF

#943
20230002345
2023-01-05

Fused ring compounds

#944
20230002329
2023-01-05

COMPOUNDS AND MODULES FOR INHIBITION OF PRE-miR-21 AND THEIR USE IN TREATMENT OF CERTAIN CANCERS

#945
20220411414
2022-12-29

INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 (BCL9) PROTEIN-PROTEIN INTERACTION

#946
20220411408
2022-12-29

Small Molecule Compound

#947
20220411400
2022-12-29

CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF

#948
20220411383
2022-12-29

AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS

#949
20220409619
2022-12-29

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#950
20220409615
2022-12-29

HTT modulators for treating Huntington's disease

#951
20220409523
2022-12-29

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID

#952
20220407026
2022-12-22

ORGANIC ELECTROLUMINESCENT DEVICE

#953
20220403383
2022-12-22

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

#954
20220402947
2022-12-22

Trialkyne linking agents and methods of use

#955
20220402921
2022-12-22

5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

#956
20220402896
2022-12-22

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

#957
20220402859
2022-12-22

Organic photodetector and electronic device including the same

#958
20220396596
2022-12-15

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#959
20220396569
2022-12-15

BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

#960
20220396566
2022-12-15

LIVER TARGETING DRUG, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#961
20220396565
2022-12-15

NOVEL HETEROCYCLIC COMPOUNDS

#962
20220396563
2022-12-15

Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders

#963
20220396562
2022-12-15

Cycloalkyl pyrimidines as ferroportin inhibitors

#964
20220395501
2022-12-15

TREATMENT OF GVHD

#965
20220388992
2022-12-08

JAK INHIBITOR COMPOUND AND USE THEREOF

#966
20220388991
2022-12-08

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE

#967
20220388990
2022-12-08

INHIBITORS OF CYCLIN-DEPENDENT KINASES

#968
20220388964
2022-12-08

(AZA)INDAZOLYL-ARYL SULFONAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

#969
20220388960
2022-12-08

ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES

#970
20220387428
2022-12-08

1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

#971
20220380387
2022-12-01

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE

#972
20220380364
2022-12-01

Anti-cancer nuclear hormone receptor-targeting compounds

#973
20220380351
2022-12-01

Organic molecules for optoelectronic devices

#974
20220380350
2022-12-01

Pyrazine-2(1H)-ketone compound preparation method

#975
20220380349
2022-12-01

PHARMACEUTICAL COMPOUNDS

#976
20220376188
2022-11-24

ORGANIC LIGHT-EMITTING DEVICE

#977
20220376186
2022-11-24

LUMINESCENCE DEVICE AND NITROGEN-CONTAINING COMPOUND FOR SAME

#978
20220372038
2022-11-24

Heterocyclic compounds and uses thereof

#979
20220371974
2022-11-24

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE

#980
20220370451
2022-11-24

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#981
20220370434
2022-11-24

METHODS AND COMPOSITIONS FOR TREATING CANCER

#982
20220367830
2022-11-17

LIGHT-EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME

#983
20220363681
2022-11-17

OXO SIX-MEMBERED CYCLOPYRIMIDINE COMPOUND, PREPARATION METHOD AND MEDICAL USE THEREOF

#984
20220363675
2022-11-17

Novel Ferroportin Inhibitors

#985
20220363670
2022-11-17

Pyrazolyl derivatives useful as anti-cancer agents

#986
20220363667
2022-11-17

T-TYPE CALCIUM CHANNEL BLOCKER

#987
20220363636
2022-11-17

4-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors

#988
20220359833
2022-11-10

Organic light-emitting device comprising emission layer satisfying specific singlet excitation energy level conditions

#989
20220356182
2022-11-10

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#990
20220356181
2022-11-10

3,5-DISUBSTITUTED PYRAZOLE COMPOUNDS AS KINASE INHIBITORS AND USES THEREOF

#991
20220356180
2022-11-10

AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES

#992
20220356173
2022-11-10

Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof

#993
20220356172
2022-11-10

Substituted 3-phenoxyazetidin-1-yl-pyrazines

#994
20220356171
2022-11-10

ISOINDOLINE DERIVATIVES

#995
20220356169
2022-11-10

TETRAZINES FOR HIGH CLICK RELEASE SPEED AND YIELD

#996
20220356167
2022-11-10

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#997
20220356153
2022-11-10

Compositions for treating neurodegenerative diseases

#998
20220348588
2022-11-03

7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same

#999
20220348562
2022-11-03

BENZIMIDAZOLE INHIBITORS OF PAD ENZYMES

#1000
20220348560
2022-11-03

N-(1H-IMIDAZOL-2-YL)BENZAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT

#1001
20220348558
2022-11-03

INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES

#1002
20220348523
2022-11-03

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE

#1003
20220348522
2022-11-03

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE

#1004
20220347175
2022-11-03

PYRIDAZINONE DERIVATIVE

#1005
20220340602
2022-10-27

HETEROCYLIC COMPOUND AND LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE HETEROCYCLIC COMPOUND

#1006
20220340581
2022-10-27

Compounds and pharmaceutical compositions thereof for the treatment of diseases

#1007
20220340547
2022-10-27

INDOLE DERIVATIVE-CONTAINING INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#1008
20220340545
2022-10-27

COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES

#1009
20220340544
2022-10-27

SUBSTITUTED HETEROCYCLIC DERIVATIVES AS PI3K INHIBITORS

#1010
20220340523
2022-10-27

Inhibitors of APOL1 and methods of using same

#1011
20220336754
2022-10-20

ORGANIC ELECTROLUMINESCENCE DEVICES

#1012
20220332743
2022-10-20

Compound, nanoribbon, and semiconductor device

#1013
20220332734
2022-10-20

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#1014
20220332723
2022-10-20

Imidazole-containing inhibitors of ALK2 kinase

#1015
20220332708
2022-10-20

SULFONAMIDE COMPOUNDS AS CARDIAC SARCOMERE ACTIVATORS

#1016
20220324846
2022-10-13

ANTIBACTERIAL COMPOUNDS

#1017
20220324845
2022-10-13

Inhibitors of LRRK2 kinase

#1018
20220324844
2022-10-13

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

#1019
20220324841
2022-10-13

THERAPEUTIC COMPOUNDS

#1020
20220324835
2022-10-13

INHIBITORS OF CBL-B AND METHODS OF USE THEREOF

#1021
20220324814
2022-10-13

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

#1022
20220324800
2022-10-13

SARS-3CL PROTEASE INHIBITORS

#1023
20220323449
2022-10-13

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

#1024
20220320446
2022-10-06

LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND

#1025
20220315563
2022-10-06

ALK-5 inhibitors and uses thereof

#1026
20220315562
2022-10-06

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

#1027
20220315560
2022-10-06

INHIBITORS OF RET

#1028
20220310932
2022-09-29

Materials for organic electroluminescent devices

#1029
20220306613
2022-09-29

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

#1030
20220306611
2022-09-29

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

#1031
20220306610
2022-09-29

COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS

#1032
20220306608
2022-09-29

Tricyclic compounds as BCR-ABL inhibitors

#1033
20220305011
2022-09-29

FACTOR XIIA INHIBITORS

#1034
20220298155
2022-09-22

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#1035
20220298154
2022-09-22

PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX

#1036
20220298146
2022-09-22

HETEROCYCLIC DERIVATIVE AND USE THEREOF

#1037
20220298144
2022-09-22

BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

#1038
20220298142
2022-09-22

HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS

#1039
20220298138
2022-09-22

ENZYME INHIBITORS

#1040
20220298120
2022-09-22

ALKYNYL QUINAZOLINE COMPOUNDS

#1041
20220293863
2022-09-15

LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME

#1042
20220291202
2022-09-15

HIGH THROUGHPUT METHOD FOR CONSTRUCTING AND SCREENING COMPOUND LIBRARY AND REACTION DEVICE

#1043
20220289769
2022-09-15

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#1044
20220289738
2022-09-15

Dihydrobenzimidazolones for medical treatment

#1045
20220289723
2022-09-15

Analogs for the treatment of disease

#1046
20220289722
2022-09-15

Crystal forms C and E of pyrazin-2(1H)-one compound and preparation method therefor

#1047
20220289720
2022-09-15

ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS

#1048
20220289719
2022-09-15

HETEROCYCLIC COMPOUNDS AS MNK INHIBITORS

#1049
20220289718
2022-09-15

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

#1050
20220289717
2022-09-15

COMPOUND, MIXTURE THEREOF, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE

#1051
20220288069
2022-09-15

INHIBITORS OF TYROSINE KINASE

#1052
20220288065
2022-09-15

MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING

#1053
20220281860
2022-09-08

COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES

#1054
20220281856
2022-09-08

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE

#1055
20220281853
2022-09-08

Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor

#1056
20220281850
2022-09-08

Bisamide sarcomere activating compounds and uses thereof

#1057
20220281845
2022-09-08

Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds

#1058
20220281842
2022-09-08

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITOR AND USES THEREOF

#1059
20220281841
2022-09-08

ETHYNYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS

#1060
20220278295
2022-09-01

LIGHT-EMITTING DEVICE INCLUDING FUSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE FUSED CYCLIC COMPOUND

#1061
20220278282
2022-09-01

ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME

#1062
20220274964
2022-09-01

5-BROMO-INDIRUBINS

#1063
20220274962
2022-09-01

Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof

#1064
20220274960
2022-09-01

QUENCHER AND USES THEREOF

#1065
20220271233
2022-08-25

Deuterium-containing compound, and organic light-emitting device comprising same

#1066
20220267364
2022-08-25

HETEROCYCLIC AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#1067
20220267307
2022-08-25

Anti-cancer compounds

#1068
20220267305
2022-08-25

Modulators of estrogen receptor proteolysis and associated methods of use

#1069
20220267256
2022-08-25

ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT

#1070
20220264880
2022-08-25

NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES

#1071
20220259188
2022-08-18

1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

#1072
20220259160
2022-08-18

METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX

#1073
20220251047
2022-08-11

HETEROCYCLIC INHIBITORS OF MCT4

#1074
20220251041
2022-08-11

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

#1075
20220246860
2022-08-04

HETEROCYCLIC COMPOUND, A LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND AN ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE

#1076
20220242853
2022-08-04

MODIFIED CYANINE DYES AND CONJUGATES THEREOF

#1077
20220242852
2022-08-04

Compounds and compositions for treating conditions associated with STING activity

#1078
20220242849
2022-08-04

WDR5 INHIBITORS AND MODULATORS

#1079
20220235065
2022-07-28

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF

#1080
20220235038
2022-07-28

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

#1081
20220235032
2022-07-28

BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

#1082
20220233545
2022-07-28

ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

#1083
20220227749
2022-07-21

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#1084
20220227738
2022-07-21

KRAS G12C INHIBITORS AND USES THEREOF

#1085
20220227736
2022-07-21

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

#1086
20220227729
2022-07-21

IDENTIFICATION AND USE OF KRAS INHIBITORS

#1087
20220220122
2022-07-14

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

#1088
20220220105
2022-07-14

Light-emitting device, light-emitting apparatus, electronic device, and lighting device

#1089
20220220096
2022-07-14

JAK1 SELECTIVE KINASE INHIBITOR

#1090
20220218849
2022-07-14

Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof

#1091
20220218704
2022-07-14

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#1092
20220216426
2022-07-07

Nitrogen-containing compound, organic electroluminescent device and electronic apparatus

#1093
20220216421
2022-07-07

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#1094
20220216409
2022-07-07

Organic Light Emitting Device

#1095
20220213069
2022-07-07

Antagonists of the muscarinic acetylcholine receptor M

#1096
20220213068
2022-07-07

Selective small molecule peptidomimetic melanocortin ligands

#1097
20220213065
2022-07-07

Aminopyrazine diol compounds as PI3K-γ inhibitors

#1098
20220211704
2022-07-07

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#1099
20220204492
2022-06-30

NOVEL HETEROCYCLIC-SUBSTITUTED PYRIMIDINE DERIVATIVE EXHIBITING CANCER CELL GROWTH INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

#1100
20220204479
2022-06-30

PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR

#1101
20220194943
2022-06-23

RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER

#1102
20220178921
2022-06-09

4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF

#1103
20220177625
2022-06-09

Curable composition, cured product, and compound

#1104
20220177489
2022-06-09

Next Generation Synthetic Transcription Factors

#1105
20220177455
2022-06-09

CRYSTAL FORMS OF A PYRIDAZINONE TRPC INHIBITOR

#1106
20220177454
2022-06-09

TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT

#1107
20220177451
2022-06-09

1-cyano-pyrrolidine derivatives as dub inhibitors

#1108
20220177450
2022-06-09

Piperazine amide derivative, preparation method therefor, and use thereof in medicine

#1109
20220175775
2022-06-09

N-substituted indole derivatives as PGE2 receptor modulators

#1110
20220173333
2022-06-02

Heterocyclic derivative and organic electroluminescent device thereof

#1111
20220170883
2022-06-02

METHOD FOR SELECTING MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE

#1112
20220169636
2022-06-02

PYRROLIDINE COMPOUNDS

#1113
20220167618
2022-06-02

PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS

#1114
20220162219
2022-05-26

Chiral bisamino-ether compounds, and method of preparation and use thereof

#1115
20220162197
2022-05-26

MYST family histone acetyltransferase inhibitors

#1116
20220162196
2022-05-26

SOLID FORMS OF A PARP7 INHIBITOR

#1117
20220162195
2022-05-26

Solid forms of an HPK1 inhibitor

#1118
20220162194
2022-05-26

Inhibitors of cysteine proteases and methods of use thereof

#1119
20220162191
2022-05-26

SMALL MOLECULE MODULATORS OF IL-17

#1120
20220162188
2022-05-26

ISOPRENOIDS AND METHODS OF MAKING THEREOF

#1121
20220153751
2022-05-19

BIFUNCTIONAL COMPOUNDS

#1122
20220153725
2022-05-19

HERBICIDALLY ACTIVE 4-(4-TRIFLUORMETHYL-6-CYCLOROPYLPYRAZOLYL)PYRIMIDINES

#1123
20220153724
2022-05-19

Inhibitors Of Plasma Kallikrein

#1124
20220153706
2022-05-19

Inhibitors of lysine specific demethylase-1

#1125
20220144813
2022-05-12

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

#1126
20220144812
2022-05-12

QUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER

#1127
20220144810
2022-05-12

Isoindolinone substituted indoles and derivatives as RAS inhibitors

#1128
20220144808
2022-05-12

Azolopyrimidine for the treatment of cancer-related disorders

#1129
20220135875
2022-05-05

PHOSPHOROUS HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

#1130
20220135598
2022-05-05

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF

#1131
20220135572
2022-05-05

COMPOUNDS AND METHODS FOR TARGETING HSP90

#1132
20220135562
2022-05-05

HETEROCYCLE-SUBSTITUTED BICYCLIC AZOLE PESTICIDES

#1133
20220135546
2022-05-05

Compounds, compositions, and methods

#1134
20220135544
2022-05-05

PYRAZOLYL QUINOXALINE KINASE INHIBITORS

#1135
20220135529
2022-05-05

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY

#1136
20220131080
2022-04-28

CARBAZOLE DERIVATES FOR USE IN OPTOELECTRONIC DEVICES

#1137
20220127264
2022-04-28

SUBSTITUTED PYRROLIDINE AMIDES II

#1138
20220127255
2022-04-28

HERBICIDAL COMPOUNDS

#1139
20220127254
2022-04-28

INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER

#1140
20220119400
2022-04-21

QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS

#1141
20220119379
2022-04-21

IMMUNOMODULATOR

#1142
20220119372
2022-04-21

Compounds and methods for inhibiting JAK

#1143
20220119371
2022-04-21

COMPOUND, COMPOSITIONS, AND METHODS

#1144
20220119370
2022-04-21

BRD4-JAK2 INHIBITORS

#1145
20220119367
2022-04-21

HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS

#1146
20220117970
2022-04-21

ARYLQUINAZOLINES

#1147
20220112164
2022-04-14

Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists

#1148
20220106299
2022-04-07

HEXONE GLUCOKINASE INHIBITOR AND USE THEREOF

#1149
20220106298
2022-04-07

BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS

#1150
20220106294
2022-04-07

SUBSTITUTED PYRROLIDINE AMIDES V

#1151
20220106287
2022-04-07

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

#1152
20220106276
2022-04-07

2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

#1153
20220098175
2022-03-31

DIRECT AMPK ACTIVATORS

#1154
20220096441
2022-03-31

TREATMENT OF ACANTHAMOEBA OR BALAMUTHIA TROPHOZOITES AND/OR CYSTS

#1155
20220089573
2022-03-24

SUBSTITUTED PYRROLIDINE AMIDES III

#1156
20220089571
2022-03-24

NLRP3 modulators

#1157
20220088043
2022-03-24

Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

#1158
20220081418
2022-03-17

Heteroaryl inhibitors of PAD4

#1159
20220079942
2022-03-17

Pyrimidinone derivatives as CDC7 inhibitors

#1160
20220077400
2022-03-10

ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

#1161
20220073536
2022-03-10

METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS

#1162
20220073514
2022-03-10

Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment

#1163
20220073499
2022-03-10

Functionalized peptides as antiviral agents

#1164
20220069234
2022-03-03

Compound for organic optoelectronic device, organic optoelectronic device, and display device

#1165
20220064189
2022-03-03

Sting agonist compounds and methods of use

#1166
20220064146
2022-03-03

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

#1167
20220064144
2022-03-03

BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS

#1168
20220064112
2022-03-03

EBNA1 inhibitors and methods using same

#1169
20220064100
2022-03-03

Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof

#1170
20220056038
2022-02-24

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

#1171
20220056019
2022-02-24

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#1172
20220056017
2022-02-24

Bicycloheptane pyrrolidine orexin receptor agonists

#1173
20220056014
2022-02-24

PHENYLPYRROLIDINE COMPOUND AND USE THEREOF

#1174
20220055988
2022-02-24

DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF

#1175
20220048899
2022-02-17

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER

#1176
20220048896
2022-02-17

PYRAZOLE COMPOUNDS SUBSTITUTED WITH HETEROARYL AND PHARMACEUTICAL USE THEREOF

#1177
20220048894
2022-02-17

Enzyme inhibitors

#1178
20220048890
2022-02-17

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

#1179
20220041630
2022-02-10

PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES

#1180
20220041592
2022-02-10

HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS

#1181
20220041587
2022-02-10

Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

#1182
20220041579
2022-02-10

SUBSTITUTED QUINOXALINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES

#1183
20220041563
2022-02-10

Compounds and Compositions for Eye Treatments

#1184
20220037593
2022-02-03

Compound and organic light emitting device comprising the same

#1185
20220033585
2022-02-03

Diamine compound, and polyimide precursor and polyimide film using same

#1186
20220033410
2022-02-03

SYNTHESIS OF NANOTUBULAR MOLECULES

#1187
20220033395
2022-02-03

INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES

#1188
20220033384
2022-02-03

Diaryl-azole compound and formulation for controlling harmful organism

#1189
20220033383
2022-02-03

FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS

#1190
20220033382
2022-02-03

Prodigiosin analogs and methods of use

#1191
20220033380
2022-02-03

Poly-ADP ribose polymerase (PARP) inhibitors

#1192
20220029107
2022-01-27

COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME

#1193
20220024919
2022-01-27

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#1194
20220024906
2022-01-27

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#1195
20220020932
2022-01-20

COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF

#1196
20220017515
2022-01-20

sGC STIMULATORS

#1197
20220017496
2022-01-20

Disubstituted pyrazole compounds

#1198
20220017495
2022-01-20

CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE

#1199
20220017493
2022-01-20

Pyrazole compounds and uses thereof

#1200
20220009910
2022-01-13

TYROSINE KINASE 2 INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF